CalciMedica, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-29.6M | $-13.7M | $-34.4M | $-7.8M | $-35.8M | $-27.5M | $-37.0M |
| Depreciation & Amortization | — | — | $58.0K | $52.0K | — | — | — |
| Depreciation | $46.0K | $58.0K | $58.0K | $52.0K | $519.0K | $395.0K | $303.0K |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.0M | $2.3M | $12.0M | $1.8M | $5.4M | $1.8M | $738.0K |
| Net Cash from Operating Activities | $-21.2M | $-21.1M | $-25.7M | $-11.8M | $-31.5M | $-32.1M | $-31.2M |
| Investing Activities | |||||||
| Capital Expenditures | $28.0K | $8.0K | $78.0K | $4.0K | $488.0K | $1.0M | $605.0K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $9.6M | $-4.4M | $8.9M | $-4.0K | $10.8M | $-42.6M | $-20.6M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $15.2M | $28.0M | $20.9M | $8.5M | $695.0K | $92.2M | $54.9M |
| Net Change in Cash | $3.6M | $2.4M | $4.1M | $-3.3M | $-20.1M | $17.5M | $3.0M |
| Free Cash Flow | $-21.2M | $-21.2M | $-25.8M | $-11.8M | $-32.0M | $-33.1M | $-31.8M |